Arg693

Site Information
PMRGGPMrGGPGPAP SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 6010035

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 )
Disease tissue studied:	testicular cancer ( 19 , 20 )
Relevant cell line - cell type - tissue:	brain ( 1 , 2 , 3 , 4 , 5 ) , embryo ( 1 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 ) , F9 (testicular) ( 20 ) , P19 (testicular) ( 19 ) , PYS-2 (epithelial) ( 18 )

References
1	Guo A, et al. (2014) Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol Cell Proteomics 13, 372-87 24129315 Curated Info
2	Guo A (2013) CST Curation Set: 18334; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -; Curated Info
3	Guo A (2013) CST Curation Set: 18335; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -; Curated Info
4	Guo A (2013) CST Curation Set: 18336; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -; Curated Info
5	Guo A (2013) CST Curation Set: 18337; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -; Curated Info
6	Guo A (2013) CST Curation Set: 18338; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
7	Guo A (2013) CST Curation Set: 18339; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
8	Guo A (2013) CST Curation Set: 18340; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
9	Guo A (2013) CST Curation Set: 18341; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
10	Guo A (2013) CST Curation Set: 18342; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
11	Guo A (2013) CST Curation Set: 18343; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
12	Guo A (2013) CST Curation Set: 18344; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
13	Guo A (2013) CST Curation Set: 18345; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
14	Guo A (2013) CST Curation Set: 18346; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
15	Guo A (2013) CST Curation Set: 18347; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
16	Guo A (2013) CST Curation Set: 18348; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
17	Guo A (2013) CST Curation Set: 18349; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -; Curated Info
18	Zhou J (2010) CST Curation Set: 9115; Year: 2010; Biosample/Treatment: cell line, PY2/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
19	Zhou J (2010) CST Curation Set: 9114; Year: 2010; Biosample/Treatment: cell line, P19/untreated; Disease: testicular cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
20	Zhou J (2010) CST Curation Set: 9111; Year: 2010; Biosample/Treatment: cell line, F9/untreated; Disease: testicular cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info